These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24516216)

  • 1. Cross-boundary cancer studies at the University of Tokyo: Astellas in Asia: challenge for cancer.
    Nogimori M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i60-64. PubMed ID: 24516216
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-boundary cancer studies at the University of Tokyo: Opening a path through research to the future of cancer treatment.
    Noda T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i43-47. PubMed ID: 24516212
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-boundary cancer studies at the University of Tokyo: Oncology in Asian countries: clinical development challenges and opportunities.
    Rigaudy P
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i54-59. PubMed ID: 24516214
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-boundary cancer studies at the University of Tokyo: Measures to control cancer in Japan.
    Kakizoe T
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i38-42. PubMed ID: 24516211
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-boundary cancer studies at the University of Tokyo: What we can do to overcome cancer.
    Kato M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i48-53. PubMed ID: 24516213
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross-boundary cancer studies at the University of Tokyo: Asia as a partner for Japan.
    Nishiyama M
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i32-37. PubMed ID: 24516210
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-boundary cancer studies at the University of Tokyo: Shining a light in the darkness: what can we see?
    Sasakawa Y
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i74-77. PubMed ID: 24516219
    [No Abstract]   [Full Text] [Related]  

  • 8. Market spiral pricing of cancer drugs.
    Light DW; Kantarjian H
    Cancer; 2013 Nov; 119(22):3900-2. PubMed ID: 24002792
    [No Abstract]   [Full Text] [Related]  

  • 9. GlaxoSmithKline cancer drug threatens Herceptin market.
    Waltz E
    Nat Biotechnol; 2005 Dec; 23(12):1453-4. PubMed ID: 16333273
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-boundary cancer studies at the University of Tokyo: International public good in the Asia-Pacific Era.
    Yachi S
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i78-83. PubMed ID: 24516220
    [No Abstract]   [Full Text] [Related]  

  • 11. Lecture No. 4 Cancer care in Asia from the perspective of latest developments in the US pharmaceutical industry.
    Eiki N
    Jpn J Clin Oncol; 2021 May; 51(12 Suppl 2):i17-i20. PubMed ID: 34002778
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-boundary cancer studies at the University of Tokyo: Surviving cancer in Asia: introduction.
    Akaza H; Kawahara N
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i1-2. PubMed ID: 24516204
    [No Abstract]   [Full Text] [Related]  

  • 13. Market watch: Upcoming catalysts in Q1 2015.
    Uribe A
    Nat Rev Drug Discov; 2015 Jan; 14(1):9. PubMed ID: 25503330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Participation in the international multi-countries study-operational issues from company view point].
    Hada S
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):324-7. PubMed ID: 17301555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-boundary cancer studies at the University of Tokyo: Food and cancer.
    Hattori Y
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i28-31. PubMed ID: 24516208
    [No Abstract]   [Full Text] [Related]  

  • 16. [International clinical trials for a medical oncologist in Japan].
    Nakagawa K
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):320-3. PubMed ID: 17301554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The malignant melanoma landscape.
    Webster RM; Mentzer SE
    Nat Rev Drug Discov; 2014 Jul; 13(7):491-2. PubMed ID: 24981356
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-boundary cancer studies at the University of Tokyo: Using genome science to decipher cancer in Asia.
    Sugano S
    Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i17-21. PubMed ID: 24516206
    [No Abstract]   [Full Text] [Related]  

  • 20. Why are cancer drugs so expensive in the United States, and what are the solutions?
    Kantarjian H; Rajkumar SV
    Mayo Clin Proc; 2015 Apr; 90(4):500-4. PubMed ID: 25792242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.